BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2621320)

  • 1. Role of tumour necrosis factor in the enhanced sensitivity of mice to endotoxin after exposure to lead.
    Dentener MA; Greve JW; Maessen JG; Buurman WA
    Immunopharmacol Immunotoxicol; 1989; 11(2-3):321-34. PubMed ID: 2621320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor necrosis factor antibody on synovial fluid cytokine activities in equine antebrachiocarpal joints injected with endotoxin.
    Hawkins DL; Cargile JL; MacKay RJ; Broome TA; Skelley LA
    Am J Vet Res; 1995 Oct; 56(10):1292-9. PubMed ID: 8928945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for IFN-gamma as a mediator of the lethality of endotoxin and tumor necrosis factor-alpha.
    Doherty GM; Lange JR; Langstein HN; Alexander HR; Buresh CM; Norton JA
    J Immunol; 1992 Sep; 149(5):1666-70. PubMed ID: 1506688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of tumor necrosis factor-alpha in down-regulation of hepatic cytochrome P450 and P-glycoprotein by endotoxin.
    Miyoshi M; Nadai M; Nitta A; Ueyama J; Shimizu A; Takagi K; Nabeshima T; Takagi K; Saito K; Hasegawa T
    Eur J Pharmacol; 2005 Jan; 507(1-3):229-37. PubMed ID: 15659313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of growth factors and of tumor necrosis factor-alpha on liver cell proliferation induced in rats by lead nitrate.
    Shinozuka H; Kubo Y; Katyal SL; Coni P; Ledda-Columbano GM; Columbano A; Nakamura T
    Lab Invest; 1994 Jul; 71(1):35-41. PubMed ID: 8041116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of treatment with a monoclonal antibody against equine tumor necrosis factor (TNF) on clinical, hematologic, and circulating TNF responses of miniature horses given endotoxin.
    Cargile JL; MacKay RJ; Dankert JR; Skelley L
    Am J Vet Res; 1995 Nov; 56(11):1451-9. PubMed ID: 8585655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.
    Eskandari MK; Bolgos G; Miller C; Nguyen DT; DeForge LE; Remick DG
    J Immunol; 1992 May; 148(9):2724-30. PubMed ID: 1315357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endotoxin-induced cytokine gene expression in vivo. II. Regulation of tumor necrosis factor and interleukin-1 alpha/beta expression and suppression.
    Ulich TR; Guo KZ; Irwin B; Remick DG; Davatelis GN
    Am J Pathol; 1990 Nov; 137(5):1173-85. PubMed ID: 2240164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue tumor necrosis factor mRNA expression following cecal ligation and puncture or intraperitoneal injection of endotoxin.
    Hadjiminas DJ; McMasters KM; Peyton JC; Cheadle WG
    J Surg Res; 1994 Jun; 56(6):549-55. PubMed ID: 8015310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody to tumor necrosis factor--alpha prevents lethal endotoxin sepsis in adult rhesus monkeys.
    Fiedler VB; Loof I; Sander E; Voehringer V; Galanos C; Fournel MA
    J Lab Clin Med; 1992 Oct; 120(4):574-88. PubMed ID: 1402333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of tumor necrosis factor antibody given to horses during early experimentally induced endotoxemia.
    Barton MH; Bruce EH; Moore JN; Norton N; Anders B; Morris DD
    Am J Vet Res; 1998 Jun; 59(6):792-7. PubMed ID: 9622754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocytopenia reduces release of soluble TNF receptor p75 in endotoxin-stimulated mice: a possible mechanism of enhanced TNF activity.
    Steinshamn S; Bemelmans MH; Buurman WA; Waage A
    Cytokine; 1995 Jan; 7(1):50-6. PubMed ID: 7749066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Failure to inhibit endotoxin-induced uveitis with antibodies that neutralize tumor necrosis factor.
    Rosenbaum JT; Boney RS
    Reg Immunol; 1993; 5(5):299-303. PubMed ID: 8148240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor (TNF) and endotoxin prime effects of PAF in vivo.
    Heuer HO; Letts G; Meade CJ
    J Lipid Mediat; 1990; 2 Suppl():S101-8. PubMed ID: 2133276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors.
    Sheehan KC; Ruddle NH; Schreiber RD
    J Immunol; 1989 Jun; 142(11):3884-93. PubMed ID: 2469726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased lactate in endotoxin-resistant mice undergoing hemorrhage is independent of tumor necrosis factor availability.
    Pellicane JV; Gore DC; DeMaria EJ
    J Surg Res; 1994 Apr; 56(4):361-6. PubMed ID: 8152231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity to endotoxin and mechanisms of host-response.
    Galanos C; Freudenberg MA; Matsuura M; Coumbos A
    Prog Clin Biol Res; 1988; 272():295-308. PubMed ID: 3393569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-alpha production and protect mice against endotoxin challenge.
    Parmely MJ; Zhou WW; Edwards CK; Borcherding DR; Silverstein R; Morrison DC
    J Immunol; 1993 Jul; 151(1):389-96. PubMed ID: 8326132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibodies to tumor necrosis factor alfa attenuate hepatic necrosis and inflammation caused by chronic exposure to ethanol in the rat.
    Iimuro Y; Gallucci RM; Luster MI; Kono H; Thurman RG
    Hepatology; 1997 Dec; 26(6):1530-7. PubMed ID: 9397994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.
    Marchant A; Bruyns C; Vandenabeele P; Ducarme M; GĂ©rard C; Delvaux A; De Groote D; Abramowicz D; Velu T; Goldman M
    Eur J Immunol; 1994 May; 24(5):1167-71. PubMed ID: 8181527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.